The image shows the compound Tat-P4-(C5)2 after an injection into the spinal cord. The compound (purple) penetrates the nerve cells of the spinal cord (yellow), but not the surrounding cells (the cell nuclei are blue). Credit: University of Copenhagen.
Researchers from the University of Copenhagen have developed a new way to treat chronic pain which has been tested in mice. With a compound designed and developed by the researchers themselves, they can achieve complete pain relief.
Between seven and ten percent of the world’s population suffers from chronic pain originating from nerves that have been damaged. A disease that can be severely debilitating. Now, researchers from the University of Copenhagen have found a new way to treat the pain.
The treatment has been tested in mice, and the new results have been published in the scientific journal EMBO Molecular Medicine. For more than a decade, the researchers have been working to design, develop and test a drug that shall provide complete pain relief.
“We have developed a new way to treat chronic pain. It is a targeted treatment. That is, it does not affect the general neuronal signalling, but only affects the nerve changes that are caused by the disease,” says co-author Kenneth Lindegaard Madsen, Associate Professor at the Department of Neuroscience, University of Copenhagen.
“We have been working on this for more than ten years. We have taken the process all the way from understanding the biology, inventing and designing the compound to describing how it works in animals, affects their behaviour and removes the pain,” says Kenneth Lindegaard Madsen.
Chronic pain can occur, among other things, after surgery, in people with diabetes, after a blood clot and after an amputation in the form of phantom pain.
Clinical trials as the next step
The compound developed by the researchers is a so-called peptide named Tat-P4-(C5)2. The peptide is targeted and only affects the nerve changes that pose a problem and cause the pain.
In a previous study, the researchers have shown in an animal model that use of the peptide can also reduce addiction. Therefore, the researchers hope that the compound may potentially help pain patients who have become addicted to, for example, opioid pain relievers in particular.
“The compound works very efficiently, and we do not see any side effects. We can administer this peptide and obtain complete pain relief in the mouse model we have used, without the lethargic effect that characterises existing pain-relieving drugs,” says Kenneth Lindegaard Madsen, adding:
“Now, our next step is to work towards testing the treatment on people. The goal, for us, is to develop a drug, therefore the plan is to establish a biotech company as soon as possible so we can focus on this.”
The researchers are now working towards clinical trials in collaboration with, among others, pain researcher Nanna Brix Finnerup, Professor at Aarhus University.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Chronic pain
- Chronic pain support from spouse may decrease well-being for some people
"But people who live with chronic pain need support over a long period of time. This research shows that if a person feels less supported or loved when they receive help, it can diminish their ...
- Deep Brain Stimulation an Option for Chronic Low Back Pain?
Early results from a trial of DBS as a potential treatment for chronic low back pain suggest the procedure was effective with no serious adverse events or complications.
- Long Dismissed, Chronic Lyme Disease Is Finally Getting Its Moment
Over the next two decades, Gray’s neurological issues continued and she progressively developed new symptoms: numbness and tingling in her back, chronic pain, anxiety, and an uncontrollable rage that ...
- Treating chronic pain requires much more than medications
When it comes to adults living with chronic pain, insurance companies are short-sighted and fail to acknowledge the science showing excellent long-term outcomes of an integrated approach to treatment.
- Health Headlines: Tricking the brain to feel less pain with Scrambler Therapy
This Scrambler therapy administers stimulation through skin electrodes and scrambles pain signals. “Do that often enough, and if you’re a person who’s responsive to Scrambler therapy, and the brain ...
Go deeper with Google Headlines on:
Chronic pain
[google_news title=”” keyword=”chronic pain” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Pain relief
- Neet Launches Topical CBD Oils for Pain Relief
Unveiling a game changer in pain relief, Neet has launched two topical products: Neet Daily Joint+ and Neet Daily NeuPain Gone. These innovative solutions offer relief through the healing prowess of ...
- The Rise of Non-Opioid Pain Management: How EXPAREL is Revolutionizing Recovery
How EXPAREL is Revolutionizing Recovery. According to the American College of Surgeons, 15 million Americans undergo surgery each year. Des ...
- Examining the mechanisms and clinical potential of a promising non-opioid pain therapy candidate
A recent publication in Scientific Reports unveils a promising non-opioid pain treatment developed by a team led by Dr. Hernan Bazan, the John Ochsner Endowed Professor of Cardiovascular Innovation at ...
- Treating chronic pain requires much more than medications
When it comes to adults living with chronic pain, insurance companies are short-sighted and fail to acknowledge the science showing excellent long-term outcomes of an integrated approach to treatment.
- InventHelp Inventor Develops New Dental Pain Relief Kit (OSK-658)
"I'm an oral and maxillofacial surgeon, and I thought there should be a way to keep patients comfortable for several days after an extraction," said an inventor, from Kitty Hawk, N.C., "so I invented ...
Go deeper with Google Headlines on:
Pain relief
[google_news title=”” keyword=”pain relief” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]